UBI — Universal Biosensors Cashflow Statement
0.000.00%
Last trade - 00:00- AU$49.18m
- AU$39.91m
- AU$6.63m
- 58
- 18
- 43
- 36
Annual cashflow statement for Universal Biosensors, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.85 | -7.64 | -10.5 | -26.9 | -6.74 |
| Depreciation | |||||
| Non-Cash Items | -2.6 | 0.544 | -0.498 | 11.7 | 0.284 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 39.2 | -3.63 | -1.46 | -2.29 | -9.13 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 33.2 | -8.29 | -9.9 | -14.7 | -14.6 |
| Capital Expenditures | -10.3 | -0.387 | -0.665 | -1.57 | -1.47 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.026 | 0.015 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -10.3 | -0.372 | -0.665 | -1.57 | -1.47 |
| Financing Cash Flow Items | — | — | — | — | -0.009 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.003 | 0.044 | 0.096 | 25 | -0.083 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 25.1 | -9.14 | -9.96 | 8.73 | -16.2 |